Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Abstract:
Naturally occurring Foxp3+CD4+ regulatory T cells (Tregs) areessential for maintaining immunological self-tolerance and immunehomeostasis. Here, we show that a specific deficiency of cytotoxicT lymphocyte antigen 4 (CTLA-4) in Tregs results in spontaneousdevelopment of systemic lymphoproliferation, fatal T cell–mediatedautoimmune disease, and hyperproduction of immunoglobulin Ein mice, and it also produces potent tumor immunity. Treg-specificCTLA-4 deficiency impairs in vivo and in vitro suppressive functionof Tregs—in particular, Treg-mediated down-regulationof CD80 and CD86 expression on dendritic cells. Thus, naturalTregs may critically require CTLA-4 to suppress immune responsesby affecting the potency of antigen-presenting cells to activateother T cells.
1 Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan. 2 Department of Rheumatology and Haematology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan. 3 Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan. 4 Laboratory of Experimental Immunology, World Premier International Immunology Frontier Research Center, Osaka University, Suita 565-0871, Japan.
* Present address: Department of Medical Inflammation Research,Karolinska Institute, Stockholm 17177, Sweden.
To whom correspondence should be addressed. E-mail: shimon{at}frontier.kyoto-u.ac.jp
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Ethan M. Shevach (10 October 2008) Science322 (5899), 202.
[DOI: 10.1126/science.1164872] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
IL-2-dependent adaptive control of NK cell homeostasis.
G. Gasteiger, S. Hemmers, P. D. Bos, J. C. Sun, and A. Y. Rudensky (2013)
J. Exp. Med.
|Abstract »|Full Text »|PDF »
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
W.-h. Kwan, W. van der Touw, E. Paz-Artal, M. O. Li, and P. S. Heeger (2013)
J. Exp. Med.
210, 257-268
|Abstract »|Full Text »|PDF »
The B7-Independent Isoform of CTLA-4 Functions To Regulate Autoimmune Diabetes.
Human CD8+ Regulatory T Cells Inhibit GVHD and Preserve General Immunity in Humanized Mice.
J. Zheng, Y. Liu, Y. Liu, M. Liu, Z. Xiang, K.-T. Lam, D. B. Lewis, Y.-L. Lau, and W. Tu (2013)
Science Translational Medicine
5, 168ra9
|Abstract »|Full Text »|PDF »
CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire.
J. Verhagen, R. Genolet, G. J. Britton, B. J. Stevenson, C. A. Sabatos-Peyton, J. Dyson, I. F. Luescher, and D. C. Wraith (2013)
PNAS
110, E221-E230
|Abstract »|Full Text »|PDF »
Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice.
T. Ishimoto, M. Shimada, G. Gabriela, T. Kosugi, W. Sato, P. Y. Lee, M. A. Lanaspa, C. Rivard, S. Maruyama, E. H. Garin, et al. (2012)
Nephrol. Dial. Transplant.
|Abstract »|Full Text »|PDF »
IL-10 Produced by Induced Regulatory T Cells (iTregs) Controls Colitis and Pathogenic Ex-iTregs during Immunotherapy.
E. G. Schmitt, D. Haribhai, J. B. Williams, P. Aggarwal, S. Jia, L.-M. Charbonnier, K. Yan, R. Lorier, A. Turner, J. Ziegelbauer, et al. (2012)
J. Immunol.
189, 5638-5648
|Abstract »|Full Text »|PDF »
Transient Deficiency of Dendritic Cells Results in Lack of a Merozoite Surface Protein 1-Specific CD4 T Cell Response during Peak Plasmodium chabaudi Blood-Stage Infection.
A.-M. Sponaas, N. Belyaev, M. Falck-Hansen, A. Potocnik, and J. Langhorne (2012)
Infect. Immun.
80, 4248-4256
|Abstract »|Full Text »|PDF »
Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
H. Xiao, Y. Luo, X. Lai, S. Fu, J. Shi, Y. Tan, J. He, W. Xie, W. Zheng, L.-M. Wang, et al. (2012)
Haematologica
97, 1804-1812
|Abstract »|Full Text »|PDF »
Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses.
L. E. Jeffery, A. M. Wood, O. S. Qureshi, T. Z. Hou, D. Gardner, Z. Briggs, S. Kaur, K. Raza, and D. M. Sansom (2012)
J. Immunol.
189, 5155-5164
|Abstract »|Full Text »|PDF »
Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
The Tumor Suppressor CYLD Controls the Function of Murine Regulatory T Cells.
S. Reissig, N. Hovelmeyer, B. Weigmann, A. Nikolaev, B. Kalt, T. F. Wunderlich, M. Hahn, M. F. Neurath, and A. Waisman (2012)
J. Immunol.
189, 4770-4776
|Abstract »|Full Text »|PDF »
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
W. Hansen, M. Hutzler, S. Abel, C. Alter, C. Stockmann, S. Kliche, J. Albert, T. Sparwasser, S. Sakaguchi, A. M. Westendorf, et al. (2012)
J. Exp. Med.
209, 2001-2016
|Abstract »|Full Text »|PDF »
Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells.
M. Vaeth, U. Schliesser, G. Muller, S. Reissig, K. Satoh, A. Tuettenberg, H. Jonuleit, A. Waisman, M. R. Muller, E. Serfling, et al. (2012)
PNAS
109, 16258-16263
|Abstract »|Full Text »|PDF »
Human regulatory T cells induce T-lymphocyte senescence.
J. Ye, X. Huang, E. C. Hsueh, Q. Zhang, C. Ma, Y. Zhang, M. A. Varvares, D. F. Hoft, and G. Peng (2012)
Blood
120, 2021-2031
|Abstract »|Full Text »|PDF »
Plasmodium inui Infection Reduces the Efficacy of a Simian Immunodeficiency Virus DNA Vaccine in a Rhesus Macaque Model Through Alteration of the Vaccine-Induced Immune Response.
J. Yin, M. T. Vahey, A. Dai, M. G. Lewis, T. Arango, J. Yalley-Ogunro, J. Greenhouse, K. Mendoza, A. Khan, N. Y. Sardesai, et al. (2012)
The Journal of Infectious Disease
206, 523-533
|Abstract »|Full Text »|PDF »
Spontaneous Autoimmunity in the Absence of IL-2 Is Driven by Uncontrolled Dendritic Cells.
S. H. Isakson, S. D. Katzman, and K. K. Hoyer (2012)
J. Immunol.
189, 1585-1593
|Abstract »|Full Text »|PDF »
Regulatory T cell properties of thymic CD4+CD25+ cells in turkeys.
Cutting Edge: Cell-Extrinsic Immune Regulation by CTLA-4 Expressed on Conventional T Cells.
C. J. Wang, R. Kenefeck, L. Wardzinski, K. Attridge, C. Manzotti, E. M. Schmidt, O. S. Qureshi, D. M. Sansom, and L. S. K. Walker (2012)
J. Immunol.
189, 1118-1122
|Abstract »|Full Text »|PDF »
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans.
Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention.
W. J. Norde, W. Hobo, R. van der Voort, and H. Dolstra (2012)
Blood
120, 728-736
|Abstract »|Full Text »|PDF »
Concurrent FOXP3- and CTLA4-associated genetic predisposition and skewed X chromosome inactivation in an autoimmune disease-prone family.
M. G. Seidel, B. Rami, C. Item, E. Schober, P. Zeitlhofer, W. D. Huber, A. Heitger, O. A. Bodamer, and O. A. Haas (2012)
Eur. J. Endocrinol.
167, 131-134
|Abstract »|Full Text »|PDF »
Identification and expansion of highly suppressive CD8+FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation.
R. J. Robb, K. E. Lineburg, R. D. Kuns, Y. A. Wilson, N. C. Raffelt, S. D. Olver, A. Varelias, K. A. Alexander, B. E. Teal, T. Sparwasser, et al. (2012)
Blood
119, 5898-5908
|Abstract »|Full Text »|PDF »
Naturally occurring regulatory T cells: markers, mechanisms, and manipulation.
K. G. Schmetterer, A. Neunkirchner, and W. F. Pickl (2012)
FASEB J
26, 2253-2276
|Abstract »|Full Text »|PDF »
IL-10+CTLA-4+ Th2 Inhibitory Cells Form in a Foxp3-Independent, IL-2-Dependent Manner from Th2 Effectors during Chronic Inflammation.
J. A. Altin, C. C. Goodnow, and M. C. Cook (2012)
J. Immunol.
188, 5478-5488
|Abstract »|Full Text »|PDF »
Basis of CTLA-4 function in regulatory and conventional CD4+ T cells.
X. Tai, F. Van Laethem, L. Pobezinsky, T. Guinter, S. O. Sharrow, A. Adams, L. Granger, M. Kruhlak, T. Lindsten, C. B. Thompson, et al. (2012)
Blood
119, 5155-5163
|Abstract »|Full Text »|PDF »
CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential.
T. Shimazu, R. Iida, Q. Zhang, R. S. Welner, K. L. Medina, J. Alberola-lla, and P. W. Kincade (2012)
Blood
119, 4889-4897
|Abstract »|Full Text »|PDF »
Loss of T Regulatory Cell Suppression following Signaling through Glucocorticoid-induced Tumor Necrosis Receptor (GITR) Is Dependent on c-Jun N-terminal Kinase Activation.
A. Joetham, H. Ohnishi, M. Okamoto, K. Takeda, M. Schedel, J. Domenico, A. Dakhama, and E. W. Gelfand (2012)
J. Biol. Chem.
287, 17100-17108
|Abstract »|Full Text »|PDF »
Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance.
M. P. Matheu, Y. Su, M. L. Greenberg, C. A. Blanc, I. Parker, D. W. Scott, and M. D. Cahalan (2012)
PNAS
109, E1258-E1266
|Abstract »|Full Text »|PDF »
Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells.
T. Duhen, R. Duhen, A. Lanzavecchia, F. Sallusto, and D. J. Campbell (2012)
Blood
119, 4430-4440
|Abstract »|Full Text »|PDF »
Requirement for Diverse TCR Specificities Determines Regulatory T Cell Activity in a Mouse Model of Autoimmune Arthritis.
S. Oh, M. Aitken, D. M. Simons, A. Basehoar, V. Garcia, E. Kropf, and A. J. Caton (2012)
J. Immunol.
188, 4171-4180
|Abstract »|Full Text »|PDF »
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
P. Yu, J. C. Steel, M. Zhang, J. C. Morris, R. Waitz, M. Fasso, J. P. Allison, and T. A. Waldmann (2012)
PNAS
109, 6187-6192
|Abstract »|Full Text »|PDF »
Multiple Associations Between a Broad Spectrum of Autoimmune Diseases, Chronic Inflammatory Diseases and Cancer.
Ligation of Cytotoxic T Lymphocyte Antigen-4 to T Cell Receptor Inhibits T Cell Activation and Directs Differentiation into Foxp3+ Regulatory T Cells.
J. Karman, J.-L. Jiang, N. Gumlaw, H. Zhao, J. Campos-Rivera, J. Sancho, J. Zhang, C. Jiang, S. H. Cheng, and Y. Zhu (2012)
J. Biol. Chem.
287, 11098-11107
|Abstract »|Full Text »|PDF »
The Immunogenetic Architecture of Autoimmune Disease.
Breakdown in Peripheral Tolerance in Type 1 Diabetes in Mice and Humans.
L. T. Jeker, H. Bour-Jordan, and J. A. Bluestone (2012)
Cold Spring Harb Perspect Med
2, a007807
|Abstract »|Full Text »|PDF »
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape.
S.-R. Woo, M. E. Turnis, M. V. Goldberg, J. Bankoti, M. Selby, C. J. Nirschl, M. L. Bettini, D. M. Gravano, P. Vogel, C. L. Liu, et al. (2012)
Cancer Res.
72, 917-927
|Abstract »|Full Text »|PDF »
Immunotherapy earns its spot in the ranks of cancer therapy.
Induction of Regulatory T Cells by a Murine {beta}-Defensin.
F. Navid, M. Boniotto, C. Walker, K. Ahrens, E. Proksch, T. Sparwasser, W. Muller, T. Schwarz, and A. Schwarz (2012)
J. Immunol.
188, 735-743
|Abstract »|Full Text »|PDF »
Human Regulatory T Cells Rapidly Suppress T Cell Receptor-Induced Ca2+, NF-{kappa}B, and NFAT Signaling in Conventional T Cells.
A. Schmidt, N. Oberle, E.-M. Weiss, D. Vobis, S. Frischbutter, R. Baumgrass, C. S. Falk, M. Haag, B. Brugger, H. Lin, et al. (2011)
Science Signaling
4, ra90
|Abstract »|Full Text »|PDF »
Higher proportions of circulating FOXP3+ and CTLA-4+ regulatory T cells are associated with lower fractions of memory CD4+ T cells in infants.
H. Rabe, A.-C. Lundell, K. Andersson, I. Adlerberth, A. E. Wold, and A. Rudin (2011)
J. Leukoc. Biol.
90, 1133-1140
|Abstract »|Full Text »|PDF »
Immune Regulation through Mitochondrion-Dependent Dendritic Cell Death Induced by T Regulatory Cells.
CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells.
T. Solstad, S. J. Bains, J. Landskron, E. M. Aandahl, B. Thiede, K. Tasken, and K. M. Torgersen (2011)
Blood
118, 5141-5151
|Abstract »|Full Text »|PDF »
Toxoplasma gondii Induces B7-2 Expression through Activation of JNK Signal Transduction.
P. Morgado, Y.-C. Ong, J. C. Boothroyd, and M. B. Lodoen (2011)
Infect. Immun.
79, 4401-4412
|Abstract »|Full Text »|PDF »
Prospects for TIM3-Targeted Antitumor Immunotherapy.
S. F. Ngiow, M. W. L. Teng, and M. J. Smyth (2011)
Cancer Res.
71, 6567-6571
|Abstract »|Full Text »|PDF »
Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells.
P. A. Beavis, B. Gregory, P. Green, A. P. Cribbs, A. Kennedy, P. Amjadi, A. C. Palfreeman, M. Feldmann, and F. M. Brennan (2011)
PNAS
108, 16717-16722
|Abstract »|Full Text »|PDF »
Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human.
F. Birzele, T. Fauti, H. Stahl, M. C. Lenter, E. Simon, D. Knebel, A. Weith, T. Hildebrandt, and D. Mennerich (2011)
Nucleic Acids Res.
39, 7946-7960
|Abstract »|Full Text »|PDF »
SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
R. Takahashi, S. Nishimoto, G. Muto, T. Sekiya, T. Tamiya, A. Kimura, R. Morita, M. Asakawa, T. Chinen, and A. Yoshimura (2011)
J. Exp. Med.
208, 2055-2067
|Abstract »|Full Text »|PDF »
Regulatory T Cells Selectively Control CD8+ T Cell Effector Pool Size via IL-2 Restriction.
W. Kastenmuller, G. Gasteiger, N. Subramanian, T. Sparwasser, D. H. Busch, Y. Belkaid, I. Drexler, and R. N. Germain (2011)
J. Immunol.
187, 3186-3197
|Abstract »|Full Text »|PDF »
Cooperative Regulation of NOTCH1 Protein-Phosphatidylinositol 3-Kinase (PI3K) Signaling by NOD1, NOD2, and TLR2 Receptors Renders Enhanced Refractoriness to Transforming Growth Factor-{beta} (TGF-{beta})- or Cytotoxic T-lymphocyte Antigen 4 (CTLA-4)-mediated Impairment of Human Dendritic Cell Maturation.
D. S. Ghorpade, S. V. Kaveri, J. Bayry, and K. N. Balaji (2011)
J. Biol. Chem.
286, 31347-31360
|Abstract »|Full Text »|PDF »
Foxp3+ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis.
L. Tian, J. A. Altin, L. E. Makaroff, D. Franckaert, M. C. Cook, C. C. Goodnow, J. Dooley, and A. Liston (2011)
Blood
118, 1845-1853
|Abstract »|Full Text »|PDF »
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4.
O. S. Qureshi, Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti, E. M. Schmidt, J. Baker, L. E. Jeffery, S. Kaur, Z. Briggs, et al. (2011)
Science
332, 600-603
|Abstract »|Full Text »|PDF »
Functional Plasticity of Antigen-Specific Regulatory T Cells in Context of Tumor.
C. Addey, M. White, L. Dou, D. Coe, J. Dyson, and J.-G. Chai (2011)
J. Immunol.
186, 4557-4564
|Abstract »|Full Text »|PDF »
Strongyloides ratti Infection Induces Expansion of Foxp3+ Regulatory T Cells That Interfere with Immune Response and Parasite Clearance in BALB/c Mice.
B. Blankenhaus, U. Klemm, M.-L. Eschbach, T. Sparwasser, J. Huehn, A. A. Kuhl, C. Loddenkemper, T. Jacobs, and M. Breloer (2011)
J. Immunol.
186, 4295-4305
|Abstract »|Full Text »|PDF »
Resolution of Severe Ipilimumab-Induced Hepatitis After Antithymocyte Globulin Therapy.
K. D. Chmiel, D. Suan, C. Liddle, B. Nankivell, R. Ibrahim, C. Bautista, J. Thompson, D. Fulcher, and R. Kefford (2011)
J. Clin. Oncol.
29, e237-e240
|Full Text »|PDF »
Experience with lentivirus-mediated CD40 gene silencing in a mouse model of Graves' disease.
F. Ye, B. Shi, X. Wu, P. Hou, L. Gao, X. Ma, L. Xu, and L. Wu (2011)
J. Endocrinol.
208, 285-291
|Abstract »|Full Text »|PDF »
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice.
T. Okazaki, I.-m. Okazaki, J. Wang, D. Sugiura, F. Nakaki, T. Yoshida, Y. Kato, S. Fagarasan, M. Muramatsu, T. Eto, et al. (2011)
J. Exp. Med.
208, 395-407
|Abstract »|Full Text »|PDF »
Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance.
V. A. Pedicord, W. Montalvo, I. M. Leiner, and J. P. Allison (2011)
PNAS
108, 266-271
|Abstract »|Full Text »|PDF »
Regulatory T Cells Interfere with Glutathione Metabolism in Dendritic Cells and T Cells.
Z. Yan, S. K. Garg, and R. Banerjee (2010)
J. Biol. Chem.
285, 41525-41532
|Abstract »|Full Text »|PDF »
Suppression of Innate Immune Pathology by Regulatory T Cells during Influenza A Virus Infection of Immunodeficient Mice.
The Role of the Basic Helix-Loop-Helix Transcription Factor Dec1 in the Regulatory T Cells.
K. Miyazaki, M. Miyazaki, Y. Guo, N. Yamasaki, M. Kanno, Z.-i. Honda, H. Oda, H. Kawamoto, and H. Honda (2010)
J. Immunol.
185, 7330-7339
|Abstract »|Full Text »|PDF »
On/Off TLR Signaling Decides Proinflammatory or Tolerogenic Dendritic Cell Maturation upon CD1d-Mediated Interaction with Invariant NKT Cells.
S. Caielli, C. Conforti-Andreoni, C. Di Pietro, V. Usuelli, E. Badami, M. L. Malosio, and M. Falcone (2010)
J. Immunol.
185, 7317-7329
|Abstract »|Full Text »|PDF »
Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease.
J.-P. Bastien, G. Krosl, C. Therien, M. Rashkovan, C. Scotto, S. Cohen, D. S. Allan, D. Hogge, R. M. Egeler, C. Perreault, et al. (2010)
Blood
116, 4859-4869
|Abstract »|Full Text »|PDF »
Stimulation of {alpha}7 Nicotinic Acetylcholine Receptor by Nicotine Increases Suppressive Capacity of Naturally Occurring CD4+CD25+ Regulatory T Cells in Mice In Vitro.
D.-w. Wang, R.-b. Zhou, Y.-m. Yao, X.-m. Zhu, Y.-m. Yin, G.-j. Zhao, N. Dong, and Z.-y. Sheng (2010)
J. Pharmacol. Exp. Ther.
335, 553-561
|Abstract »|Full Text »|PDF »
Cutting Edge: Mechanisms of IL-2-Dependent Maintenance of Functional Regulatory T Cells.
L. Barron, H. Dooms, K. K. Hoyer, W. Kuswanto, J. Hofmann, W. E. O'Gorman, and A. K. Abbas (2010)
J. Immunol.
185, 6426-6430
|Abstract »|Full Text »|PDF »
The Protein Tyrosine Phosphatase SHP-1 Modulates the Suppressive Activity of Regulatory T Cells.
T. Iype, M. Sankarshanan, I. S. Mauldin, D. W. Mullins, and U. Lorenz (2010)
J. Immunol.
185, 6115-6127
|Abstract »|Full Text »|PDF »
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.
K. Noonan, L. Marchionni, J. Anderson, D. Pardoll, G. D. Roodman, and I. Borrello (2010)
Blood
116, 3554-3563
|Abstract »|Full Text »|PDF »
Harnessing Regulatory T cells to Suppress Asthma: From Potential to Therapy.
Naive Human T Cells Are Activated and Proliferate in Response to the Heme Oxygenase-1 Inhibitor Tin Mesoporphyrin.
T. D. Burt, L. Seu, J. E. Mold, A. Kappas, and J. M. McCune (2010)
J. Immunol.
185, 5279-5288
|Abstract »|Full Text »|PDF »
A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota.
T. Chinen, P. Y. Volchkov, A. V. Chervonsky, and A. Y. Rudensky (2010)
J. Exp. Med.
207, 2323-2330
|Abstract »|Full Text »|PDF »
Chemoimmunotherapy Reduces the Progression of Multiple Myeloma in a Mouse Model.
A. Sharabi, A. Laronne-Bar-On, A. Meshorer, and N. Haran-Ghera (2010)
Cancer Prevention Research
3, 1265-1276
|Abstract »|Full Text »|PDF »
Endotoxin tolerance attenuates airway allergic inflammation in model mice by suppression of the T-cell stimulatory effect of dendritic cells.
H. Matsushita, S. Ohta, H. Shiraishi, S. Suzuki, K. Arima, S. Toda, H. Tanaka, H. Nagai, M. Kimoto, A. Inokuchi, et al. (2010)
Int. Immunol.
22, 739-747
|Abstract »|Full Text »|PDF »
T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency.
C. E. Teh, S. R. Daley, A. Enders, and C. C. Goodnow (2010)
PNAS
107, 14709-14714
|Abstract »|Full Text »|PDF »
Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology.
P. B. Ernst, J. C. Garrison, and L. F. Thompson (2010)
J. Immunol.
185, 1993-1998
|Abstract »|Full Text »|PDF »
Foxp3+ CD4 Regulatory T Cells Limit Pulmonary Immunopathology by Modulating the CD8 T Cell Response during Respiratory Syncytial Virus Infection.
R. B. Fulton, D. K. Meyerholz, and S. M. Varga (2010)
J. Immunol.
185, 2382-2392
|Abstract »|Full Text »|PDF »
Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis.
S. Shafiani, G. Tucker-Heard, A. Kariyone, K. Takatsu, and K. B. Urdahl (2010)
J. Exp. Med.
207, 1409-1420
|Abstract »|Full Text »|PDF »
Genetics of Type 1 Diabetes: What's Next?.
F. Pociot, B. Akolkar, P. Concannon, H. A. Erlich, C. Julier, G. Morahan, C. R. Nierras, J. A. Todd, S. S. Rich, and J. Nerup (2010)
Diabetes
59, 1561-1571
|Full Text »|PDF »
Role Played by CD4+ FOXP3+ Regulatory T Cells in Suppression of Host Responses to Haemophilus ducreyi during Experimental Infection of Human Volunteers.
W. Li, K. Tenner-Racz, P. Racz, D. M. Janowicz, K. R. Fortney, B. P. Katz, and S. M. Spinola (2010)
The Journal of Infectious Disease
201, 1839-1848
|Abstract »|Full Text »|PDF »